Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature
Authors:
- 1 February 2005
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 78 (2) , 142-150
Abstract
Eradication of Helicobacter pylori (H. pylori ) from the gastric mucosa has been associated with improvement of several systemic diseases, including immune thrombocytopenic purpura (ITP). Over the last 5 years, several studies have reported improved platelet counts in H. pylori‐positive ITP patients following standard triple H. pylori eradication therapy. Review of published studies in which eradication of H. pylori has been performed in the ITP population indicates an overall response rate of 52% in 193 subjects in whom H. pylori was eradicated. Cohorts from Japan and Italy report higher response rates. There is no established mechanism to explain how this organism, which does not invade the gastric mucosa, could be implicated in the pathogenesis of this immune‐based platelet disorder. Several theories including molecular mimicry, platelet aggregation, and immunomodulatory effects of macrolides have been proposed to explain the platelet response to anti‐H. pylori therapy. Large randomized‐controlled studies enrolling patients from various ethnic backgrounds will be necessary to determine the response rate and mechanism of response and to gain a better understanding of the pathogenesis of ITP. Am. J. Hematol. 78:142–150, 2005.Keywords
This publication has 80 references indexed in Scilit:
- Helicobacter pylori and Idiopathic Thrombocytopenic PurpuraAnnals of Internal Medicine, 2004
- NSAIDs,Helicobacter pylori,and Pandora's BoxNew England Journal of Medicine, 2002
- Helicobacter pyloriInfectionNew England Journal of Medicine, 2002
- Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritisAlimentary Pharmacology & Therapeutics, 2002
- The Genetic Gymnastics of Our Indigenous MicrobesNew England Journal of Medicine, 2002
- Helicobacter pylori and autoimmune neutropeniaClinical and Laboratory Haematology, 2002
- Remission of idiopathic thrombocytopenic purpura after eradication of Helicobactor pylori. Report of two cases.Nihon Naika Gakkai Zasshi, 2001
- Role of Helicobacter pylori infection in pernicious anaemiaDigestive and Liver Disease, 2000
- Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action ofHelicobacter pyloriand other bacterial infections in increasing cardiovascular riskEuropean Heart Journal, 1998
- Helicobacter pylori infection and primary Sjögren's syndrome: a possible association and new therapeutic approachCurrent Therapeutic Research, 1995